Servings 1 / Serving size 0.8 oz (23g)
Amount per serving: Calories 100
Total Fat 5g (6% DV), Saturated Fat 1g (5% DV), Sodium 35mg (2% DV), Total Carbohydrate 8g (3% DV), Dietary Fiber 3g (11% DV), Total Sugars 4g (Includes 1g Added Sugars, 2% DV), Protein 3g, Not a significant source of trans fat, cholesterol, vitamin D, calcium, iron and potassium. The % Daily Value (DV) tells you how much a nutrient in a serving of food contributes to a daily diet. 2000 calories a day is used for general nutrition advice.
Cashews*, Tapioca Fiber*, Dates*, Amaranth Seeds*, Gluten-free Oat Flour*, Fairtrade Semi-Sweet Chocolate* (Fairtrade Coconut Sugar*, Fairtrade Chocolate Liquor*, Fairtrade Cocoa Butter*), Vanilla Extract*, Himalayan Pink Sea Salt and Brahmi Powder
Experiments on animals strongly indicate the value of Brahmi as a promising agent in AD and other forms of cognitive impairment. Due to small sample size of human trials, we recommend large multicentric clinical trials to confirm biosafety profile of Brahmi and also to explore its additional and serious side effects. Comparative studies between Brahmi and similar allopathic medicines are essential to evaluate the efficacy and safety profile of the erstwhile therapies.
BM demonstrates immense potential in the amelioration of cognitive disorders, as well as prophylactic reduction of oxidative damage, NT modulation, and cognitive enhancement in healthy people. Biomedical research on BM is still in its infancy, but preliminary results such as these have begun to open the research floodgates.
It has been envisaged that in this century, disorders of the central nervous system will have a significant bearing on the healthcare concerns of the human population worldwide. Such neurological and psychiatric disorders are generally associated with loss of memory, cognitive deficits, impaired mental function etc. Due to the multi-factorial nature of these diseases, modern medicine based psychoactive drugs have met with limited success.